trending Market Intelligence /marketintelligence/en/news-insights/trending/zbas0dc9vpdgqgmjxxt8hg2 content esgSubNav
In This List

Sarepta Therapeutics adds director

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Sarepta Therapeutics adds director

Sarepta Therapeutics Inc. has appointed Mary Ann Gray to the board.

Gray is president of Gray Strategic Advisors LLC, a biotechnology strategic planning and advisory firm. Previously, she was on the boards of Senomyx Inc., Juniper Pharmaceuticals Inc., TetraLogic Pharmaceuticals Corp. and ACADIA Pharmaceuticals Inc.

Cambridge, Mass.-based Sarepta Therapeutics focuses on the discovery and development of RNA-based therapeutics, gene therapy and other genetic medicine approaches for treating rare neuromuscular diseases.